ARID1A and bladder transitional cell carcinoma: Moreover, direct evidence of ARID1A’s tumor suppressor capability in urothelial bladder cancer cells is scarce and we thus analyzed the effect of ARID1A protein loss on growth of urothelial cells as well as potential underlying mechanisms.